The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124172432 12417243 2 F 20140822 20160714 20160530 20160725 EXP IT-ELI_LILLY_AND_COMPANY-IT201605006247 ELI LILLY AND CO 90.66 YR F Y 0.00000 20160722 CN IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124172432 12417243 1 PS HUMALOG MIX75/25 INSULIN LISPRO 1 Subcutaneous 6 U, QD U U 20563 6 IU INJECTION QD
124172432 12417243 2 SS HUMALOG MIX75/25 INSULIN LISPRO 1 Subcutaneous UNK UNK, QD U U 20563 INJECTION QD
124172432 12417243 3 SS Insulin glargine INSULIN GLARGINE 1 Subcutaneous 10 U, UNK U U 0 10 IU INJECTION QD
124172432 12417243 4 SS Insulin Lispro INSULIN LISPRO 1 Subcutaneous 4 U, EACH MORNING U U 0 4 IU QD
124172432 12417243 5 SS Insulin Lispro INSULIN LISPRO 1 Subcutaneous 6 U, QD U U 0 6 IU QD
124172432 12417243 6 SS Insulin Lispro INSULIN LISPRO 1 Subcutaneous 4 U, EACH EVENING U U 0 4 IU QD
124172432 12417243 7 SS Insulin Lispro INSULIN LISPRO 1 Subcutaneous 14 U, QD U U 0 14 IU QD
124172432 12417243 8 SS LANTUS INSULIN GLARGINE 1 Subcutaneous UNK UNK, QD U U 0 INJECTION QD
124172432 12417243 9 SS LANTUS INSULIN GLARGINE 1 Subcutaneous 10 U, QD U U 0 10 IU INJECTION QD
124172432 12417243 10 SS APIDRA INSULIN GLULISINE 1 Subcutaneous 16 U, QD U U 0 16 IU INJECTION QD
124172432 12417243 11 C INSULIN GLARGINE INSULIN GLARGINE 1 Subcutaneous 12 U, QD U U 0 12 IU INJECTION QD
124172432 12417243 12 C ACENOCOUMAROL ACENOCOUMAROL 1 Oral 4 MG, UNKNOWN U 0 4 MG TABLET
124172432 12417243 13 C ENALAPRIL ENALAPRIL 1 Oral 5 MG, UNKNOWN U 0 5 MG TABLET
124172432 12417243 14 C WARFARIN WARFARIN 1 Oral 5 MG, UNKNOWN U 0 5 MG TABLET
124172432 12417243 15 C Clexane ENOXAPARIN SODIUM 1 Subcutaneous U 0
124172432 12417243 16 C Clexane ENOXAPARIN SODIUM 1 U 0
124172432 12417243 17 C Ferro-Grad C 2 Oral U 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124172432 12417243 1 Type 2 diabetes mellitus
124172432 12417243 3 Type 2 diabetes mellitus
124172432 12417243 4 Type 2 diabetes mellitus
124172432 12417243 8 Type 2 diabetes mellitus
124172432 12417243 10 Type 2 diabetes mellitus
124172432 12417243 11 Type 2 diabetes mellitus
124172432 12417243 12 Aortic valve replacement
124172432 12417243 13 Hypertension
124172432 12417243 14 Aortic valve replacement

Outcome of event

Event ID CASEID OUTC COD
124172432 12417243 OT
124172432 12417243 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124172432 12417243 Cardiac arrest
124172432 12417243 Face injury
124172432 12417243 Hyperglycaemia
124172432 12417243 Hypoglycaemic coma
124172432 12417243 Hypoglycaemic unconsciousness
124172432 12417243 Loss of consciousness
124172432 12417243 Prothrombin time shortened
124172432 12417243 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124172432 12417243 1 20140822 0
124172432 12417243 4 20160422 0
124172432 12417243 8 20160308 0
124172432 12417243 10 20130828 0